StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.18−0.18 (-12.96%)

Close on Nov 16, 2026Market cap $61.66MP/E –Yield –

OKYO Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

OKYO Pharma's total debt was $2.70M at Mar 31, 2025. For fiscal 2025 it was $2.70M.

Annual total debt

PeriodPeriod endValueChange
FY2025Mar 31, 2025$2.70M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ1 2025Mar 31, 2025$2.70M–

More OKYO Pharma figures

See a number that looks wrong?